Kenneth A. Bauer, MD
Professor of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical SchoolYou Make the Call
- Is it reasonable to use rivaroxaban as an antithrombotic drug in obese patients?
Thursday, January 1st, 2015
Kenneth A. Bauer, MDProfessor of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School This month, Kenneth A. Bauer, MD, advises on the use of target-specific oral anticoagulants in obese patients. CLINICAL DILEMMA Is it reasonable to use rivaroxaban as an antithrombotic drug in patients with very-high body mass index (>40 kg/m²)? EXPERTS MAKE THE CALL [...]
